MétaCan
Menu
Back to cohort

Characterization of neuroendocrine prostate cancer (NEPC) in patients with metastatic castration resistant prostate cancer (mCRPC) resistant to abiraterone (Abi) or enzalutamide (Enz): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WCDT).

2015· article· en· W2311347322 on OpenAlexaff
Eric J. Small, Jiaoti Huang, Jack Youngren, Artem Sokolov, Rahul Aggarwal, George Thomas, Lawrence D. True, Li Zhang, Adam Foye, Joshi J. Alumkal, Charles J. Ryan, Matthew B. Rettig, Christopher P. Evans, Martin Gleave, Robert Baertsch, Joshua M. Stuart, Robert E. Reiter, Primo N. Lara, Kim N., Tomasz M. Beer

Bibliographic record

VenueJournal of Clinical Oncology · 2015
Typearticle
Languageen
FieldMedicine
TopicProstate Cancer Treatment and Research
Canadian institutionsBC Cancer Agency
Fundersnot available
KeywordsEnzalutamideProstate cancerMedicineMetastasisHistologyProstateCancerPTENBiopsyAdenocarcinomaPathologyOncologyCancer researchInternal medicineAndrogen receptorBiologyPI3K/AKT/mTOR pathway

Abstract

fetched live from OpenAlex

5003 Background: Mechanisms of resistance to androgen signaling inhibitors such as Abi or Enz are poorly understood. An increasing % of these pts develop NEPC. Pathologic (path), clinical, and genomic characterization of pts with NEPC was undertaken in the context of the WCDT project, which seeks to identify genetic pathways underlying primary and acquired resistance to Abi and Enz. Methods: Eligible mCRPC pts underwent a metastasis (met) biopsy (bx) at one of 5 WCDT centers, using a standardized bx protocol, and were uniformly followed for clinical outcomes. Tissue was both frozen, and formalin fixed/paraffin embedded. Independent path review was undertaken by 3 pathologists. Frozen specimens underwent laser capture micro-dissection, RNA isolation, library preparation and RNA sequencing (seq). Machine learning was used to derive a NEPC expression signature. Results: 150 of 300 planned mCRPC pts have undergone bx. Path review has been undertaken in 101. Classic small cell cancer (SmCC) was identified in 12%, adenocarcinoma (adenoca) in 33%. An intermediate histology distinct from SmCC or adenoca was seen in 27%. The remaining 28% were mixed histologies or were not classifiable. Anatomic site of bx (node, bone, liver) did not appear to enrich for a particular histology. Median overall survival was: not reached at 22 mos of follow-up in pts with adenoca, 8.9 mos in pts with intermediate histology, and 6.6 mos in pts with SmCC (log rank p = 0.027). RNAseq data are available on 45 biopsies. A 50 gene signature with 97% accuracy for NEPC (defined as SmCC or intermediate histology) was developed. Conclusions: RNAseq and expression analysis can be accomplished in small bone and soft tissue mCRPC biopsies. A distinct histology, intermediate to SmCC and adeno, was observed in 27% of pts. The development of NEPC in mCRPC resistant to Abi or Enz is far more common than previously appreciated and appears to result in poor survival. A 50 gene NEPC expression signature was derived which provides insight into the biology and potential treatment of NEPC.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.002
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.559
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.001
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.097
GPT teacher head0.420
Teacher spread0.323 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations60
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicProstate Cancer Treatment and ResearchFrench-language works237,207